A BuiltForAI Property
Live data · NADAC + Part D CY24 · reviewed daily

Bisoprolol (Bisoprolol)

Beta-Adrenergic Blocker class · 11 generic manufacturers · 23 ANDAs filed at FDA.

First FDA approval2000-11-16
Generic availableYes · 11 mfrs
Shortage statusNone
340B exposureunknown
Last updated
NADAC: weekly (every Wed)Part D Formulary: quarterlyPart D Spend: annual (CY24)Orange Book: weeklyShortages: daily
At a glance · the numbers a plan sponsor wants on screen one

$44.2M in CY2024 Part D spend1.7M claims · 547K beneficiaries · 329 plans surveyed

Lowest NADAC
$0.157/unit
20 NDCs benchmarked, lowest of all strengths.
Average NADAC
$0.157
Across all dosage forms in distribution.
Highest NADAC
$0.157
Range is tight.
Plans with PA
0 / 329
Zero PA friction — switching is purely formulary.

Questions a plan sponsor actually asks.

FAQPage schema10 entries indexed · 4 visible
What is Bisoprolol used for?

Bisoprolol is a Beta-Adrenergic Blocker medication tracked in Medicare Part D.

Is there a generic for Bisoprolol?

Yes. 23 ANDAs filed at FDA, 11 generic manufacturers currently shipping.

How much does my plan pay for Bisoprolol?

Across 329 Part D plans, Bisoprolol averages $0.157/unit (NADAC). Lowest available: $0.157/unit. Highest in distribution: $0.157/unit.

Is Bisoprolol on the FDA shortage list?

No. Bisoprolol is not currently on the FDA Drug Shortage Database.

6 additional drug-specific questions are indexed in the page's FAQPage schema for search engines and LLM crawlers, beyond what renders visually above. View page source for the complete JSON-LD.

Same class. Different math.

Beta-Adrenergic Blocker2 alternatives in D1
01
Metoprolol
Brand: KAPSPARGO
$0.017Lowest NADAC
31Generic mfrs
$853.0MCY24 Part D spend
Compare →
02
Propranolol
Brand: HEMANGEOL
$0.051Lowest NADAC
15Generic mfrs
$164.2MCY24 Part D spend
Compare →

Sources · every number above traces back.

Last refresh30 May 2026

Drug identity, dosage forms, brand names: openFDA NDC Directory · First approval, ANDA history: FDA Orange Book (10 approvals on file) · NADAC unit costs: CMS NADAC weekly file (20 NDCs benchmarked) · Formulary tier and PA placement: CMS Part D Formulary file (329 plans) · Annualized spend, claims, beneficiaries: CMS Part D Spending Dashboard (CY2024) · Shortage status: FDA Drug Shortage Database · 340B exposure: HRSA OPAIS. Methodology and reproducibility notes on /methodology.